Healthcare Is Deploying AI Tools — It’s Not Ready for AI Colleagues
Most healthcare organizations are experimenting with AI. Few are preparing to manage AI agents as participants in everyday healthcare workflows.
Most healthcare organizations are experimenting with AI. Few are preparing to manage AI agents as participants in everyday healthcare workflows.
While organizations have invested heavily in expanding ambulatory networks, many are discovering that operational workflows have not evolved at the same pace. The result is a growing gap between demand and the systems designed to manage it.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Drug development isn't limited by the amount of data we collect, but by our ability to preserve the context, meaning and relationships that transform data into evidence.
Hospitals that see improved long-term results in behavioral health patients will be those that prioritize metrics aligned with their care pathways.
They are vast, deep, and nearly impossible to navigate without the right clinical lens applied on top. The real challenge facing health data platform companies and health system data teams is what to do with all of it.
Once data starts moving across multiple systems, it becomes hard to track unless you’ve been very intentional about it from the start.
The problem isn’t that CQI no longer matters. It’s that traditional approaches were never built for the scale and complexity many agencies are now dealing with.
Timely, usable data closes care gaps and improves operations, but healthcare organizations lack access.
When every metric is treated as important, nothing actually stands out. Leaders spend more time interpreting data than acting on it. And in a system as complex as healthcare, delays in decision-making can have real operational and financial consequences.
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable.
The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning.
Uma (Veerappan) Nuggehalli of Flare Capital Partners thinks the healthcare AI startups that will come out on top will be companies that integrate seamlessly into workflows, build proprietary datasets and quickly determine how to sell their technology.
Healthcare is pouring money into AI, but poor data quality is quietly sabotaging results by scaling bias, errors, and mistrust instead of value. Until organizations fix historical data, set accuracy baselines, and keep humans in the loop, AI will multiply problems faster than it improves outcomes.
If leading hospitals are using these AI tools, and the companies mention HIPAA compliance on their websites, are the consumer AI health tools also regulated by HIPAA? Do consumers share a similar relationship with these companies as healthcare organizations do?